Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
16 May 2024 | Story Anthony Mthembu | Photo Lutendo Mabata
Prof Marlize Rabe
Prof Marlize Rabe, Vice-Dean of Teaching and Learning in the Faculty of Humanities at the University of the Free State (UFS).

The University of the Free State (UFS) proudly announces the appointment of Prof Marlize Rabe as Vice-Dean of Teaching and Learning in the Faculty of The Humanities. Commencing her tenure on 1 April 2024, Prof Rabe brings a wealth of experience and a vision for advancing pedagogical excellence within the academic community.

Reflecting on her new role, Prof Rabe expressed enthusiasm, stating, “Being part of this esteemed faculty is an exciting prospect. I hope to add value through this appointment by working with lecturers and students on various levels.”

Previously serving as Head of the Sociology Department at the University of the Western Cape (UWC), Prof Rabe’s academic journey positions her uniquely to navigate the responsibilities of her new portfolio, drawing from her extensive experience in undergraduate and postgraduate education.

What this new role entails

The scope of Prof Rabe’s role encompasses multifaceted aspects, including management and administration. She elaborates,’’In many instances, this position offers an opportunity to identify common ground and foster collaborations, thus facilitating the growth of all stakeholders involved.” Such collaborations, she emphasises, are pivotal in propelling the faculty towards innovation and pioneering approaches to teaching and learning.

What to expect in the near future

Looking ahead, Prof Rabe outlines forthcoming initiatives aimed at enhancing the academic landscape. Notably, a colloquium scheduled for the second semester will explore the integration of Artificial Intelligence (AI) in assessments, ensuring relevance and accessibility for both educators and students. As it is, a dedicated task team within the faculty is poised to spearhead these transformative endeavours.

Furthermore, Prof Rabe wants to focus on quality assurance in the faculty. ‘’We must be accountable to our students to maintain the highest standards of education,” she asserts, underscoring the imperative of continual evaluation and benchmarking against global best practices.

In celebration of Prof Rabe’s appointment, the University of the Free State extends its warmest congratulations, anticipating a future marked by innovation, collaboration, and academic excellence under her leadership. 

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept